NCT00241488
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Beijing, China
- Ching Qing, China
- Guangzhou, China
- Harbin, China
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,309 public trials
330 recruiting studies
Lipid Metabolism Disorders trial results
NCT00605787
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia, +7 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
NCT00350038
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Sanofi-aventis Budapest, Hungary
NCT00115232
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemias, +13 more
- Locations
-
- Children's Hospital Boston Boston, Massachusetts, United States
NCT00222833
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +15 more
- Locations
-
- Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States
NCT00287404
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
- Locations
-
- University of North Carolina Diabetes Care Center Durham, North Carolina, United States
NCT00574782
- Conditions
- CVA, Cardiovascular Diseases, Coronary Disease, +16 more
- Locations
-
Not specified
NCT00335699
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Research Site Daegu, South Korea
- Research Site Iksan, South Korea
- Research Site Jeonju, South Korea
- Research Site Jinju, South Korea
NCT00405197
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemia, +16 more
- Locations
-
- Hospital Gelderse Vallei Ede, Netherlands
- Wageningen University, Division of Human Nutrition Wageningen, Netherlands
NCT00134173
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Fresno, California, United States